fbpx

references

American Psychological Association (2017). Anxiety. Retrieved from http://www.apa.org/topics/anxiety/

Black, Rosemary (2019). Ketamine for Depression: What Is Ketamine Treatment? Retrieved from www.psycom.net/ketamine-depression

Das, R.K., Gale, G., Walsh, K. et al. Ketamine can reduce harmful drinking by pharmacologically rewriting drinking memories. Nat Commun 10, 5187 (2019). Retrieved from https://doi.org/10.1038/s41467-019-13162-w

Ezquerra-Romano I, Ivan, Lawn W, Krupitsky E, Morgan CJA. Ketamine for the treatment of addiction: Evidence and potential mechanisms. Neuropharmacology. 2018 Nov;142:72-82. Retrieved From DOI: 10.1016/j.neuropharm.2018.01.017.

Feder, A., Parides, M., Murrough J., Perez A., Morgan, J., Saxena, S., Kirkwood, K., Aan het Rot, M., Lapidus K., Wan, L., Iosifescu, D., & Charney D. (2014). “Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: A randomized clinical trial.” JAMA Psychiatry. 2014;71(6):681–688. doi:10.1001/jamapsychiatry.2014.62

Fond, Guillaume, et al. “Ketamine administration in depressive disorders: a systematic review and meta-analysis.” Psychopharmacology 231.18 (2014): 3663-3676.

Fitzgibbon, Edward J., and Raymond Viola. “Parenteral ketamine as an analgesic adjuvant for severe pain: development and retrospective audit of a protocol for a palliative care unit.” Journal of palliative medicine 8.1 (2005): 49-57.

Grados, M., Atkins, E., Kovacikova, G., & McVicar, E. (2015). “A selective review of glutamate pharmacological therapy in obsessive-compulsive and related disorders.” Psychology Research and Behavior Management. 8, 115-131

Graven-Nielsen, T, et al. “Ketamine Reduces Muscle Pain, Temporal Summation, and Referred Pain in Fibromyalgia Patients.” Pain, U.S. National Library of Medicine, Apr. 2000, www.ncbi.nlm.nih.gov/pubmed/10781923.

Hartley, C., & Phelps, E. (2012). Extinction learning. Retrieved from https://link.springer.com/referenceworkentry/10.1007%2F978-1-4419-1428-6_306

Health Rising, “Ketamine and Fibromyalgia: An Overview.” Retrieved from www.healthrising.org/treating-chronic-fatigue-syndrome/drugs/ketamine/.

Helpman, L., Marin, M.-F., Papini, S., Zhu, X., Sullivan, G. M., Schneier, F., … Neria, Y. (2016). “Neural changes in extinction recall following prolonged exposure treatment for PTSD: A longitudinal fMRI study.” NeuroImage : Clinical, 12, 715–723

Hyde, S. (2015). Ketamine for depression. Xlibris

Matthew, S., & Zarate, A. (2016.) “Ketamine for treatment-resistant depression: The first decade of progress.” Springer International Publishing

Meisner, Robert C. (2017). Ketamine for Major Depression: New Tool, New Questions. Retrieved from www.apna.org/m/pages.cfm?pageid=6603

Mercadante, Sebastiano, et al. (2000). “Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study.” Journal of pain and symptom management 20.4 (2000): 246-252.

National Institute of Mental Health (2016). Post-traumatic stress disorder. Retrieved from https://www.nimh.nih.gov/health/topics/post-traumatic-stress-disorder-ptsd/index.shtml

National Institute of Mental Health (2016). Obsessive compulsive disorder. Retrieved from https://www.nimh.nih.gov/health/topics/obsessive-compulsive-disorder-ocd/index.shtml

Niesters M, Martini C, Dahan A. “Ketamine for chronic pain: risks and benefits.” Br J Clin Pharmacol. 2014;77(2):357–367. doi:10.1111/bcp.12094

Orhurhu, Vwaire MD, MPH*; Orhurhu, Mariam Salisu MD, MPH†; Bhatia, Anuj MD, FRCPC‡; Cohen, Steven P. MD§,‖ Ketamine Infusions for Chronic Pain: A Systematic Review and Meta-analysis of Randomized Controlled Trials, Anesthesia & Analgesia: July 2019 – Volume 129 – Issue 1 – p 241-254 doi: 10.1213/ANE.0000000000004185

Pickering AE, McCabe CS. Prolonged ketamine infusion as a therapy for complex regional pain syndrome: synergism with antagonism?. Br J Clin Pharmacol. 2014;77(2):233‐238. doi:10.1111/bcp.12157

Prommer, Eric E. “Ketamine for pain: an update of uses in palliative care.” Journal of palliative medicine 15.4 (2012): 474-483.

Psychiatry Advisor Contributing Writer. “Ketamine and Future Depression Treatments.” Psychiatry Advisor, 17 Oct. 2019. Retrieved from www.psychiatryadvisor.com/home/depression-advisor/ketamine-and-future-depression-treatments/.

Sigtermans, Marnix J, et al. “Ketamine Produces Effective and Long-Term Pain Relief in Patients with Complex Regional Pain Syndrome Type 1.” Pain, U.S. National Library of Medicine, Oct. 2009, www.ncbi.nlm.nih.gov/pubmed/19604642.

Sörensen, J, et al. “Pain Analysis in Patients with Fibromyalgia. Effects of Intravenous Morphine, Lidocaine, and Ketamine.” Scandinavian Journal of Rheumatology, U.S. National Library of Medicine, 1995. Retrieved from www.ncbi.nlm.nih.gov/pubmed/8610220.

U.S. Department of Veteran Affairs (2017). What is PTSD? Retrieved from https://www.ptsd.va.gov/public/ptsd-overview/basics/what-is-ptsd.asp

World Health Organization (2017). Mental disorders. Retrieved from http://www.who.int/mental_health/management/en/

CHECK OUT OUR GOOGLE REVIEWS